Gavi COVAX AMC Summit/Japan – “One World Protected”

Gavi COVAX AMC Summit/Japan – “One World Protected”

World leaders unite to commit to global equitable access for COVID-19 vaccines

News Releases

2 June 2021 

:: The Gavi COVAX AMC Summit “One World Protected” virtual event, hosted today by the Government of Japan and Gavi, the Vaccine Alliance, raised US$ 2.4 billion from nearly 40 donor governments, the private sector and foundations, exceeding the funding target and bringing the total pledged to the COVAX AMC to US$ 9.6 billion to date

:: Japan demonstrated its commitment to ending the acute phase of the pandemic by pledging US$ 800 million at the Summit, making their total contribution to the COVAX AMC US$ 1 billion. Their leadership made way for other donors to help COVAX fulfill its financial ask

:: The funds raised will enable Gavi to secure 1.8 billion doses of COVID-19 vaccines for lower-income countries participating in the COVAX Facility

:: The vaccines, to be delivered in 2021 and early 2022, will enable COVAX to protect almost 30% of the population in 91 AMC economies

:: In addition, five countries made new commitments to donate more than 54 million vaccine doses to lower-income countries, including through COVAX, to bridge short-term supply challenges. This brings the total number of doses shared to more than 132 million

:: Suga Yoshihide, Prime Minister, Japan – “I made the decision on our contribution, hoping to deliver vaccines, a ray of hope, to as many people as possible, and as early as possible, throughout the world, in an equitable manner. It is our responsibility to overcome the current pandemic crisis and prepare for future health crises, thereby leading the world to ‘build back better’.”

:: José Manuel Barroso, Chair, Gavi Board – “Thanks to all our donors, we can now protect not only health care workers, the elderly and other vulnerable people but broader sections of the population, increasing our chances further of bringing the pandemic under control.”

Tokyo / Geneva, 2 June 2021 – World leaders joined forces today at the “One World Protected” – Gavi COVAX Advance Market Commitment (AMC) Summit hosted by Japanese Prime Minister Suga Yoshihide and Gavi Board Chair José Manuel Barroso to pledge their support to the Gavi COVAX Advance Market Commitment (AMC), securing US$ 2.4 billion, reaching a total of US$ 9.6 billion for COVID-19 vaccine procurement. In addition, donors have pledged US$ 775 million for vaccine delivery.

This funding will allow the COVAX AMC to secure 1.8 billion fully subsidised doses for delivery to lower-income countries and economies in 2021 and early 2022. This is enough to protect nearly 30% of the adult population in AMC-eligible economies. The funds raised will also support COVAX to diversify its vaccine portfolio in times of supply uncertainty and new variant emergence, and to plan the scenarios and strategy for public health needs for 2022 and beyond…

   … Alongside the financial pledges, first dose-sharing donations were announced by Belgium, Denmark and Japan, as well as additional pledges from Spain and Sweden, boosting short-term supplies by over 54 million vaccine doses.  

The European Investment Bank (EIB) has stepped up to support African Union countries with EUR 300 million financing to access vaccines via the COVAX cost-sharing scheme – leveraging domestic resources to procure safe and efficacious vaccines through COVAX.

This EIB EUR 300 million financing announcement is the path forward towards an aggregate commitment of US$ 1 billion from multilateral development banks and international financing institutions to support a cost-sharing initiative enabling AMC-eligible economies to use domestic resources to purchase additional vaccines through COVAX. This will facilitate them to take advantage of COVAX’s global logistics system, globally negotiated volume and prices, and other critical benefits such as the COVAX No-Fault Compensation Scheme Programme.

Elsewhere in the Summit programme, commitments were made to free up supply chains and remove bottlenecks that restrict or slow down the distribution of COVID-19 vaccines, raw materials and components. Vaccine manufacturers have reaffirmed their support to COVAX as the only global solution to ending the acute phase of the pandemic.

OUTCOMES OF THE GLOBAL VACCINE SUMMIT

New financial commitments to the Gavi COVAX AMC

At the event today, a number of donor governments announced significant new commitments worth a total of US$ 2.4 billion towards the 2021 goal. This includes:

  • US$ 800 million from Japan
  • AU$ 50 million from Australia
  • EUR 2.6 million from Austria
  • CAD 220 million from Canada
  • EUR 70’000 from Estonia
  • EUR 10 million from Finland
  • EUR 100 million from France
  • ISK 500 million from Iceland
  • US$ 40 million from Kuwait
  • CHF 100’000 from Lichtenstein
  • EUR 1 million from Luxembourg
  • EUR 40’000 from Malta
  • US$ 2’500 from Mauritius
  • US$ 250’000 from Mexico
  • US$1 million from Oman
  • EUR 750’000 from Poland
  • US$ 1 million from Philippines
  • EUR 50 million from Spain
  • CHF 125 million from Switzerland
  • US$ 500’000 from Viet Nam
  • In addition, the autonomous communities of Basque Country, Catalonia and Extremadura of the Kingdom of Spain have collectively pledged almost EUR 1 million to the Gavi COVAX AMC

The Bill & Melinda Gates Foundation today announced a US$ 50 million commitment to both: the Gavi COVAX Advance Market Commitment (AMC), to purchase COVID-19 vaccines; and to Gavi, the Vaccine Alliance, to support the delivery of these vaccines to lower-income countries and economies. In addition to these, private sector partners also mobilised significant new resources totalling more than US$ 300 million for the Gavi COVAX AMC. New partners such as UBS Optimus Foundation and Twilio joined COVAX, and existing partners such as Google.org, Mastercard and Visa Foundation increased their commitments in support of vaccine equity. Individuals also contributed to COVAX through the Vaccine Forward Initiative and the Go Give One campaign.

New dose-sharing commitments to the Gavi COVAX AMC and lower-income countries and economies:

The Summit also saw a number of new dose-sharing commitments, amounting to 54 million, supporting the Gavi COVAX AMC in its immediate supply needs. These included:

  • 30 million vaccine doses to the COVAX Facility, other countries and economies produced in Japan
  • 4 million vaccine doses donated by Belgium to the COVAX Facility
  • 3 million vaccine doses donated by Denmark primarily to the COVAX Facility
  • 15 million vaccine doses donated by Spain to the COVAX Facility (on top of the 7.5 million previously pledged)
  • 2 million vaccine doses donated by Sweden to the COVAX Facility (on top of the 1 million previously pledged)